FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426238006: Lapatinib ditosylate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2663017017 Lapatinib ditosylate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2674886012 Lapatinib ditosylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
40111000188117 Lapatinib ditosylate fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lapatinib ditosylate (substance) Is a Lapatinib (substance) false Inferred relationship Some
Lapatinib ditosylate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein-tyrosine kinase inhibitor (disposition) true Inferred relationship Some
Lapatinib ditosylate (substance) Is a Quinazoline (substance) true Inferred relationship Some
Lapatinib ditosylate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Lapatinib (substance) true Inferred relationship Some
Lapatinib ditosylate (substance) Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Lapatinib ditosylate (substance) Is a Enzyme inhibitor false Inferred relationship Some
Lapatinib ditosylate (substance) Is a Epidermal growth factor receptor inhibitor true Inferred relationship Some
Lapatinib ditosylate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Epidermal growth factor receptor inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lapatinib ditosylate (substance) Inferred relationship Some
Lapatinib ditosylate monohydrate (substance) Is a False Lapatinib ditosylate (substance) Inferred relationship Some
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lapatinib ditosylate (substance) Inferred relationship Some 1
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Lapatinib ditosylate (substance) Inferred relationship Some 1
Lapatinib ditosylate monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Lapatinib ditosylate (substance) Inferred relationship Some
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Lapatinib ditosylate (substance) Inferred relationship Some 1
Product containing precisely lapatinib (as lapatinib ditosylate) 250 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Lapatinib ditosylate (substance) Inferred relationship Some 1
Lapatinib ditosylate anhydrous This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Lapatinib ditosylate (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start